KP, Prior require injury treatment

A recurrence of Kevin Pietersen's chronic knee problems have added to England's injury concerns less than a fortnight from the start of their Ashes defence in Brisbane.

Kevin Pietersen leaves the field after being dismissed by Australia A swing bowler Trent Copeland during England's tour match in Hobart. Photo: Gareth Copley Source: Getty Images

INJURIES and bad weather are threatening to derail England's Ashes campaign, with star batsman Kevin Pietersen fearing he may break down.

Pietersen was forced to fly to Melbourne on Sunday for a cortisone injection to an damaged knee, while wicket-keeper Matt Prior requires a scan on a calf strain suffered during England's washed out match against Australia A.

The first Test begins in Brisbane on Thursday week.

Hobart's weather has served as a major hindrance to England's Ashes preparations.

"I'm working on my legs, hoping my legs hold up because I've had the knee issue, so I've just got to make sure the rehab continues," Pietersen told the ECB website.

"Because I could break down and I don't want to break down.

"I want to play the whole series."

Pietersen has not played international cricket for two months after suffering the knee injury against New Zealand and put off surgery with the hope of playing in the Ashes.

He made scores of 6, 5 and 0 to finish the one-day series against Australia in England last September and did not play again until last week against Australia A in Hobart.

England's Ashes preparations have suffered a further setback with an injury scare to Matt Prior.

Pietersen missed the opening match of the tour in Perth after travelling to a friend's memorial service in South Africa, arriving in Australia three days after his team mates.

With more than two days of rain in Hobart ruining the four-day match against Australia A, Pietersen was able to bat only once, scoring eight in 10 balls.

England's last lead-up match is a four-day game against an invitation XI in Sydney, which has a dodgy weather forecast all week.

Coach Andy Flower is still hopeful Pietersen will be able play in the match, beginning on Wednesday.

"Kevin has had a slight reoccurrence of that knee issue, and he'll be going to Melbourne for a scan and a cortisone injection," Flower said.

"I don't think it's going to be a huge issue. He's had a couple of these injections before, and they've been successful.

"They've quietened the problem down, and it's obviously an ongoing issue for him.

"But they have been successful, and we anticipate this one being successful and anticipate him playing a full part in the Ashes tour.

"He's got a little bit of time for the jab to work before we train on Tuesday.

"We anticipate him playing in the Sydney game."

View the original article here

NY's Barclays Center box holders claim shabby treatment due to race

By Ellen Wulfhorst

NEW YORK | Thu Oct 31, 2013 8:16pm EDT

NEW YORK (Reuters) - A group of Barclays Center luxury box holders sued the giant events center in Brooklyn on Thursday, claiming they have been treated badly because they are black.

The federal lawsuit filed by Ludwig's Drug Store, which seeks $4 million in damages, claims its manager and two other staffers who bought into the box have been "harassed, followed and questioned."

The three men say they are the only black box holders at Barclays, which opened in September 2012 and can hold as many as 19,000 people. It has 101 luxury suites, according to its website.

The Brooklyn-based drug store signed a three-year lease for nearly $1 million for a luxury box three weeks ago, according to the lawsuit.

Since then, the three say in the lawsuit they have been treated with suspicion, ignored by staff, forced to wait long times for orders that sometimes never arrive and once were billed $1,000 for a pizza that arrived late and was cold. Their luxury box is rarely cleaned, they say.

The complaint is the latest in a string of accusations of racism at commercial spots in New York.

Several black customers complained in recent days that they were stopped by police after making luxury purchases at Barneys New York and at Macy's Inc, and Barneys and the police were named in a lawsuit filed by a student who said he was detained after buying an expensive belt.

The complaints against the stores have prompted an investigation by the state attorney general into their security practices.

The treatment by Barclays is "unlawful discriminatory practice because of race," said the lawsuit filed in U.S. District Court in Brooklyn.

Barclays spokesman Barry Baum said in a statement that it would "immediately and thoroughly" investigate the claims.

"We have a zero tolerance policy for any type of discriminatory behavior. It is against everything that Barclays Center stands for," Baum said, noting that Barclays had not received legal papers nor complaints from the box holders.

The attorney representing the three men declined to speak to the media, his office said.

In the year since it has opened, Barclays has hosted shows by such top performers as Jay Z, Barbra Streisand, the Rolling Stones and Paul McCartney. It is home to the Brooklyn Nets and will be home to the New York Islanders professional hockey team starting in 2015.

(Editing by Richard Chang)

View the original article here

Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting

Main Category: Bio-terrorism / Terrorism
Article Date: 04 Feb 2013 - 0:00 PST Current ratings for:
Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting

In an advance toward closing a major gap in defenses against terrorist attacks and other mass casualty events, scientists are reporting discovery of a promising substance that could be the basis for development of a better antidote for cyanide poisoning. Their report, which describes a potential antidote that could be self-administered, much like the medication delivered by allergy injection pens, appears in ACS' Journal of Medicinal Chemistry.

Steven E. Patterson, Ph.D., and colleagues at the University of Minnesota Center for Drug Design explain that the only existing antidotes for cyanide - recognized as a high-risk substance for potential use by terrorists - must be administered by intravenous infusion. That procedure requires highly trained paramedical personnel and takes time. Cyanide, however, is a fast-acting poison. In a situation involving mass casualties, only a limited number of victims could be saved. Patterson's team thus sought an antidote that could be administered by intra-muscular (IM) injection, a simpler procedure that could be administered rapidly to a large number of victims or even be self-administered.

Their report describes discovery of a substance, sulfanegen TEA, "which should be amenable for development as an IM injectable antidote suitable for treatment of cyanide victims in a mass casualty setting. Further development, including efficacy in lethal cyanide animal models, will be reported at a later date."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our bio-terrorism / terrorism section for the latest news on this subject. The authors acknowledge financial support from the National Institutes of Health through the National Institute of Neurological Disorders and Stroke (award #UO1NS058087-05).
American Chemical Society Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Chemical Society. "Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting." Medical News Today. MediLexicon, Intl., 4 Feb. 2013. Web.
5 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.

'Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here